Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of Ultrasound, Hysteroscopy, and Histology in Postmenopausal Women: A Five-Year Retrospective Observational Study in Dubai.

Cureus·2026
Same author

Genetic, Epidemiological, and Clinical Risk Factors for Perinatal Anxiety and Depression in Dubai: Protocol for a 2-Point Prospective Observational Study.

JMIR research protocols·2025
Same author

A Complicated Case of Thrombotic Thrombocytopenic Purpura in Pregnancy with Superimposed Preeclampsia.

Oman medical journal·2024
Same author

Is there a difference in the clinical profile and outcome of women using levonorgestrel IUD for abnormal uterine bleeding and those using it for contraception?: A comparative cross-sectional study.

Turkish journal of obstetrics and gynecology·2024
Same author

Massive serous cyst adenoma with ovarian abscess causing fatal septicaemia.

BMJ case reports·2023
Same author

Exome sequencing in the pediatric neuromuscular clinic leads to more frequent diagnosis of both neuromuscular and neurodevelopmental conditions.

Muscle & nerve·2023

Related Experiment Video

Updated: Jul 7, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Polyhydramnios. Risk factors and outcome.

Mariam Mathew1, Shabnam Saquib, Syed G Rizvi

  • 1Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, Sultan Qaboos University Hospital, Al-Khoud 123, Muscat, Sultanate of Oman. mathewz@omantel.net.om

Saudi Medical Journal
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Polyhydramnios, excess amniotic fluid, is linked to increased maternal age, diabetes, and fetal macrosomia. Pregnancies with polyhydramnios show higher rates of anemia, cesarean delivery, and congenital anomalies.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Experiment Videos

Last Updated: Jul 7, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Perinatology

Background:

  • Polyhydramnios, characterized by excessive amniotic fluid, is a pregnancy complication with potential adverse maternal and fetal outcomes.
  • Identifying risk factors and understanding outcomes are crucial for effective management.

Purpose of the Study:

  • To identify risk factors associated with polyhydramnios.
  • To evaluate maternal and perinatal outcomes in pregnancies complicated by polyhydramnios.

Main Methods:

  • A prospective study was conducted on deliveries with polyhydramnios from January 2005 to April 2006.
  • Polyhydramnios was classified as mild or moderate to severe based on amniotic fluid index.
  • Demographic data, antenatal complications, delivery details, and perinatal outcomes were analyzed.

Main Results:

  • Polyhydramnios occurred in 7.8% of deliveries, with 86.1% classified as mild.
  • Diabetes in pregnancy (32.7%) and fetal macrosomia were significantly associated with polyhydramnios.
  • Higher rates of preterm delivery (7.7%), cesarean delivery (27.9%), and congenital anomalies (2.8%) were observed in the polyhydramnios group.

Conclusions:

  • Maternal age, diabetes in pregnancy, and fetal macrosomia are significant risk factors for polyhydramnios.
  • Pregnancies with polyhydramnios are associated with increased risks of anemia, cesarean delivery, and congenital anomalies, necessitating close monitoring.